What question did this study set out to answer?

The study aims to evaluate bleeding-related outcomes after TURP in patients on chronic antiplatelet or anticoagulant therapy with perioperative medication interruption.

June 11, 2026BMC UrologyOpen Access

Bleeding-related outcomes after transurethral resection of prostate in patients with chronic antiplatelet or anticoagulant therapy following perioperative interruption: a retrospective cohort study

View Full Paper

Ask AI

Bookmark

Authors

AİAbdullah İlktaçBezmiâlem Vakıf Üniversitesi BDBayram DoganBezmiâlem Vakıf Üniversitesi CECevper ErsözIstanbul Medipol University

Discussion

Member takes

Implication

Retrospective cohort study assesses bleeding-related complications in TURP patients on antithrombotic therapy, highlighting significant risks.

Key Points

The study aims to evaluate bleeding-related outcomes after TURP in patients on chronic antiplatelet or anticoagulant therapy with perioperative medication interruption.
Retrospective study including patients who underwent TURP from January 2020 to December 2024.
Patients were classified into control, antiplatelet (AP), and anticoagulant (AC) groups based on therapy use.
Evaluated outcomes included postoperative blood transfusion, clot retention, hematuria-related readmission, and other parameters.
325 patients included: 198 control, 97 AP, and 30 AC.
Significant differences in postoperative transfusion (p=0.001) and hematuria-related readmission rates (p=0.032) between groups.
Antiplatelet therapy identified as an independent predictor of hematuria readmission (OR:4.17, p=0.010).

Cite This Study

İlktaç et al. (2026) studied this question.

synapsesocial.com/papers/6a2a523480c8f91e7f39e3e8 https://doi.org/10.1186/s12894-026-02220-3

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort study assesses bleeding-related complications in TURP patients on antithrombotic therapy, highlighting significant risks.

Bleeding-related outcomes after transurethral resection of prostate in patients with chronic antiplatelet or anticoagulant therapy following perioperative interruption: a retrospective cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

Bleeding-related outcomes after transurethral resection of prostate in patients with chronic antiplatelet or anticoagulant therapy following perioperative interruption: a retrospective cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider